Navigation Links
Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology
Date:3/14/2011

delivered with Inovio's electroporation device; the 12-patient comparison group will receive standard-of-care treatment alone. The study has received approval from the Swedish Medical Products Agency and local ethical committee.

"If we can repeat the Phase I results in this phase IIb study there is certainly a possibility that vaccination with ChronVac-C® before drug therapy could become a part of the standard of care therapy for patients with chronic hepatitis C-virus infection. In particular, we hope that vaccination with this novel therapy will result in a considerable shortening of the duration of interferon and ribavirin treatment," said Anders Vahlne, CEO of ChronTech Pharma AB.

Dr. J. Joseph Kim, Inovio's president and CEO, said: "We are encouraged by the phase I results showing the improved cure rate in patients who received the HCV vaccine followed by a SOC drug therapy. Any improvement to the HCV standard of care response rates would be well-received by HCV patients and practitioners. We are pleased to collaborate in this advancement of ChronVac-C®, using Inovio's innovative delivery technology, into Phase II."

About Hepatitis C Virus

Hepatitis C virus (HCV) infection is the most common chronic blood borne infection in the United States, where approximately 3.5 million persons have been chronically infected. Worldwide, about 300 million people have been infected with HCV. Based on current statistics for hepatitis C, it is estimated that 8,000 to 10,000 people die each year from chronic liver disease caused by this condition. Chronic HCV infection is the leading indication for liver transplants in the United States. Total health costs associated with hepatitis C virus in the U.S. are estimated at more than $15 billion per year. No vaccine for HCV is currently available.

About Inovio's Electroporation-Based Delivery Technology

Inovio's electroporation-based DNA delivery systems can increase
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
2. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
3. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
6. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
7. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
8. Onyx Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
9. Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named Woman of the Year by Arthritis Foundation
10. Conatus Pharmaceuticals Will Display HCV Clinical Trial Data at the International Liver Congress™ (EASL) in March
11. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... -- According to a new market research ... (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral), by ... to 2020", published by MarketsandMarkets, the Transfection Reagents and ... by 2020 with a CAGR of 7.2% from 2014 ... ables and 33 F igures ...
(Date:7/1/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/nk3569/future_horizons ... "Future Horizons and Growth Strategies in the European ... Forecasts" report to their offering. ... Blood Banking Market 2015 is a new five-countrystrategic ... and potential market entrants identify and evaluate emerging ...
(Date:7/1/2015)... MARLBOROUGH, Mass. , July 1, 2015 Boston ... call discussing financial results and business highlights for the second ... at 8 a.m. ET. The call will be ... officer, and Dan Brennan , executive vice president and ... conference call will be available via the Boston Scientific website. ...
Breaking Medicine Technology:Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 2Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 4European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 2
... TechniScan (OTC Bulletin Board: TSNI ), a ... an automated 3D breast ultrasound imaging system, announced today that ... with Austin, Texas-based Womens3D. These agreements follow ... January 2011 in which they agreed to jointly develop a ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ... company,s president and chief executive officer, is scheduled ... Markets Healthcare ConferenceWednesday, March 2, 20119:00 a.m. Eastern ... Health Care Conference Tuesday, March 8, 201111:00 a.m. ...
Cached Medicine Technology:Breast Imaging Company, TechniScan, Signs Manufacturing Agreement With Texas Company 2
(Date:7/1/2015)... ... 01, 2015 , ... After conducting a nationwide executive ... Medical Center in Oceanside, Calif., has hired Cheryle Bernard-Shaw as chief compliance ... adaptation efforts and growing a focus on risk management, Bernard-Shaw will assume her ...
(Date:7/1/2015)... ... ... Incentivizing the use of generic drugs has been an easy way for plans ... off the prices for the brand-name products. But now that generics are experiencing record ... these high-cost generic drugs. The July issue of Atlantic Information Services, Inc.’s (AIS) The ...
(Date:7/1/2015)... ... 01, 2015 , ... Northbound Treatment Services announced today that ... , Emily originally entered the behavioral healthcare industry as an academic director ... curriculum for clients to engage in their educational journey while in treatment. In ...
(Date:7/1/2015)... ... ... Thule Atmos X4 offers protection with minimal bulk. At the Thule Test Center™, ... Due to its Bi-ComponentArmor and ShockStop corners, it passed Thule’s 2 meter drop test, ... The Thule Atmos X4 has also been designed with function in mind. The ...
(Date:7/1/2015)... Raton, FL (PRWEB) , ... July 01, 2015 , ... ... wide range of nutritional and beauty products, recently attended the 2015 ECRM Diet, Vitamin ... big-time connections in the retail industry. The ECRM trade show allows companies ...
Breaking Medicine News(10 mins):Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2Health News:NPI Meets With Top Retail Figures at ECRM Conference 2
... , THURSDAY, Sept. 15 (HealthDay News) -- Children typically don,t die ... Thursday that 115 kids younger than 18 died from flu-related causes ... many of the deaths could have been prevented if the children ... U.S. Centers for Disease Control and Prevention. , , ...
... protein linked to cell division and migration and tied to ... high levels in breast cancer specimens and cell lines. The ... in breast cancer cells than in normal breast cells. ... findings and others in a paper now online in the ...
... News) -- Experts around the world have issued a call ... A group of international medical bodies said physicians can ... and it also urged governments to take action and address ... in preventable and premature disease, affecting 76 million people globally. ...
... Clinic have received a grant from the National Institutes of ... test that conclusively identifies concussions in college football players. ... after a game searches for a biomarker known as ... in an athlete,s blood. Damir Janigro, Ph.D., and Nicola ...
... -- Not enough children and teens drink low-fat milk, a ... Prevention reveals. Drinking milk is important for children,s bone ... the calcium, vitamin D and other nutrients found in milk, ... milk products to avoid unnecessary fat and calories. ...
... In order to better prevent blood clots, the drugs ... acute ischaemia of the heart muscle, in addition to ... Efficiency in Health Care (IQWiG) has now investigated whether, ... coronary intervention (PCI), the combination of prasugrel plus ASA ...
Cached Medicine News:Health News:Flu Killed 115 Children Last Season: CDC 2Health News:Flu Killed 115 Children Last Season: CDC 3Health News:Study finds protein critical to breast cancer cell proliferation, migration 2Health News:Doctors Urged to Lead Battle Against Alcohol Abuse 2Health News:Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test 2Health News:Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test 3Health News:Not Enough Kids Drink Low-Fat Milk, U.S. Study Finds 2Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 2Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 3Health News:Prasugrel: Indications of an additional benefit for some patients, but also of greater harm 4
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
... surgical-quality loupes available at manufacturer-direct ... innovative optical design, combining superior quality ... with maximum comfort, SheerVision loupes are ... worldwide. Make both a professional and ...
... surgical-quality loupes available at manufacturer-direct ... innovative optical design, combining superior quality ... with maximum comfort, SheerVision loupes are ... worldwide. Make both a professional and ...
... the first manufacturer to offer through-the-lens ... wearer. These next generation loupes feature ... ultra-lightweight design, and are multi-coated lens ... With SheerVision's proprietary SureFit system - ...
Medicine Products: